Research Library

The top resource for free research, white papers, reports, case studies, magazines, and eBooks.

Share Your Content with Us
on for readers like you. LEARN MORE
Development and Verification of the HTG EdgeSeq Reveal Immune, Stroma and TME Signatures
Request Your Free White Paper Now:

"Development and Verification of the HTG EdgeSeq Reveal Immune, Stroma and TME Signatures"

Immune response to a malignant tumor is a known indicator in predicting patient response to therapy. Historically, tumor immune response has been characterized using immunohistochemistry, but, more recently, gene expression profiling based on next-generation sequencing has emerged as an alternative to classify a tumor’s inflammation status.

This white paper describes the development and verification of three new oncology signatures for classifying a tumor’s inflammation status: the HTG EdgeSeq Reveal Immune, Stroma, and Tumor Microenvironment signatures. These signatures are built upon the HTG EdgeSeq research use only Precision ImmunoOncology Panel. The data presented demonstrate that the HTG EdgeSeq Immune, Stroma, and TME scores offer an accurate and robust method for determining the inflammation and stroma status of tumor FFPE samples.

Offered Free by: HTG Molecular Diagnostics
See All Resources from: HTG Molecular Diagnostics

Recommended for Professionals Like You: